PIMA541867
Vapaliximab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA541867-Each-of-1 | In Stock | ₹ 44,020.62 |
PIMA541867 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,020.62
GST (18%): ₹ 7,923.712
Total Price: ₹ 51,944.332
Antigen
Vapaliximab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
2D10
Immunogen
Human AOC3/VAP-1
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA, SDS-Page
Concentration
0.47 mg/mL
Formulation
PBS with no preservative; pH 7.4
Host Species
Human
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
IgG2 κ
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Vapaliximab is a biosimilar that targets AOC3
- Copper amine oxidases catalyze the oxidative conversion of amines to aldehydes in the presence of copper and quinone cofactor
- The product is a major protein on the adipocyte plasma membrane
- It has adhesive properties and also has functional monoamine oxidase activity
- A pseudogene for this gene has been discribed and is located approximately 9-kb downstream.
Compare Similar Items
Show Difference
Antigen: Vapaliximab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: 2D10
Immunogen: Human AOC3/VAP-1
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 0.47 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG2 κ
Antigen:
Vapaliximab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
2D10
Immunogen:
Human AOC3/VAP-1
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
0.47 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG2 κ
Antigen: Lemalesomab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: IMMU-MN3; 78NCA-90; NCA-90
Immunogen: Human NCA-90
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Mouse
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1
Antigen:
Lemalesomab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
IMMU-MN3; 78NCA-90; NCA-90
Immunogen:
Human NCA-90
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Mouse
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1
Antigen: Bivatuzumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: BIWA4
Immunogen: Human CD44 /CD44V
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 3.4 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Bivatuzumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
BIWA4
Immunogen:
Human CD44 /CD44V
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
3.4 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Sibrotuzumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: BIBH1
Immunogen: Human FAP
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 2.44 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Sibrotuzumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
BIBH1
Immunogen:
Human FAP
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
2.44 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ